US Health Officials Call for Shots Against Pneumonia

2026年11月09日 80点热度 0人点赞 0条评论

美国卫生官员呼吁接种肺炎疫苗

 

📖 逐句对照翻译

American health officials say people age 50 and older should get vaccinated against bacteria that cause pneumonia and other dangerous diseases.

美国卫生官员表示,50岁及以上人群应接种疫苗,以预防引起肺炎和其他危险疾病的细菌。

Pneumonia is an infection that affects the lungs.

肺炎是一种影响肺部的感染。

It makes breathing difficult and can cause a rise in body temperature.

它会使呼吸困难,并可能导致体温升高。

Pneumonia can also lead to a cough that produces yellow, green or bloody substances.

肺炎还可能导致咳嗽,咳出黄色、绿色或带血的物质。

The advice, or recommendation, was offered by a group of scientific advisors and approved by the Centers for Disease Control and Prevention (CDC).

这项建议(或称推荐)由一组科学顾问提出,并获得了美国疾病控制与预防中心(CDC)的批准。

The former age recommendation for adult vaccinations was 65 and older.

此前成人疫苗接种的年龄建议为65岁及以上。

CDC Director Mandy Cohen said in a statement, “Now is a great time to get vaccinated against pneumococcal disease in preparation for the winter respiratory season.”

CDC主任曼迪·科恩在一份声明中表示:“现在是接种肺炎球菌疫苗的好时机,为冬季呼吸道疾病高发季做好准备。”

The advisors voted 14-1 to change the age recommendation during an October meeting in Atlanta, Georgia, home of the CDC headquarters.

顾问们在10月于佐治亚州亚特兰大(CDC总部所在地)举行的一次会议上,以14比1的投票结果决定更改年龄建议。

Doctors widely follow the agency’s guidance.

医生们广泛遵循该机构的指导。

Pneumococcal shot recommendations are sometimes called the most complex vaccination guidance that the government issues.

肺炎球菌疫苗接种建议有时被称为政府发布的最复杂的疫苗接种指南。

The CDC currently recommends shots for children younger than five and adults 50 or older, as long as they have never been vaccinated against pneumococcal disease.

CDC目前建议5岁以下儿童和50岁及以上成年人接种疫苗,前提是他们从未接种过肺炎球菌疫苗。

Officials also recommend the shots for children and adults at increased risk for pneumococcal disease, such as those with diabetes, liver disease or a weakened immune, or defense, system.

官员还建议为感染肺炎球菌疾病风险较高的儿童和成人接种疫苗,例如患有糖尿病、肝病或免疫系统较弱的人。

There are more than 100 known kinds of pneumococcal bacteria.

已知的肺炎球菌细菌种类超过100种。

They can cause serious infections in the lungs and other parts of the body.

它们可能在肺部及身体其他部位引发严重感染。

Each year, the U.S. sees about 30,000 cases of pneumococcal disease, which includes blood infections, brain and spine inflammation, and other problems.

每年,美国约有3万例肺炎球菌疾病病例,包括血液感染、大脑和脊柱炎症以及其他问题。

About 30 percent of cases are among people aged 50 to 64.

大约30%的病例发生在50至64岁的人群中。

The first pneumococcal vaccine was licensed in the U.S. in 1977.

第一种肺炎球菌疫苗于1977年在美国获批上市。

Since then, drugmakers have been coming up with newer versions that target several bacteria in a single shot.

自那以后,制药公司不断推出更新的版本,只需一针就能针对多种细菌。

There are four vaccines now in use.

目前有四种疫苗在使用中。

They include Prevnar 20 from Wyeth-Pfizer, and Vaxneuvance and Pneumovax 23 made by Merck.

它们包括惠氏-辉瑞公司的Prevnar 20,以及默克公司生产的Vaxneuvance和Pneumovax 23。

The U.S. Food and Drug Administration this year also approved Merck’s Capvaxive, which can cost around $300 a treatment.

美国食品药品监督管理局今年还批准了默克公司的Capvaxive,每个疗程的费用约为300美元。

The new shot can protect against 21 kinds of bacteria, including eight not included in other pneumococcal vaccines.

这种新疫苗可预防21种细菌,其中包括其他肺炎球菌疫苗未涵盖的8种。

A Merck spokesperson said it is designed to help protect against the bacteria that cause the majority of severe disease in adults aged 50 and older.

默克公司的一位发言人表示,该疫苗旨在帮助预防那些导致50岁及以上成年人大多数严重疾病的细菌。

In June, the CDC advisors recommended the vaccine as a possible shot for adults at higher risk.

6月,CDC顾问建议将该疫苗作为高风险成年人的可选接种方案。

At the time, the group also talked about the possibility of lowering the age recommendation for older adults.

当时,该小组还讨论了降低老年人年龄建议的可能性。

They noted that infections causing sickness peak at age 55 to 59 among Black Americans — a lower age than found among white Americans.

他们指出,在黑人美国人中,导致疾病的感染在55至59岁达到高峰——这一年龄低于白人美国人的高峰年龄。

Some scientists have concerns about the CDC recommendation.

一些科学家对CDC的建议表示担忧。

They say a second treatment, called a booster, may be necessary in about 15 years.

他们说,大约15年后可能需要进行第二次治疗,即所谓的加强针。

And some new vaccines in development could force another update to the recommendations.

而一些正在研发的新疫苗可能会迫使建议再次更新。

Dr. Jamie Loehr is the chair of the committee’s pneumococcal working group.

杰米·洛尔博士是该委员会肺炎球菌工作小组的主席。

He was the only person to vote against the proposal.

他是唯一投票反对该提案的人。

He said, “Pneumococcal has been a very confusing recommendation for many, many years and it’s hard to have a new recommendation every two or three years.”

他说:“多年来,肺炎球菌的推荐建议一直非常令人困惑,而且很难每两三年就有一个新的推荐建议。”

I'm Caty Weaver.

我是凯蒂·韦弗。

Hai Do adapted this story for VOA Learning English based on reporting from The Associated Press and information from the Centers for Disease Control and Prevention.

海杜根据美联社的报道以及美国疾病控制与预防中心的信息,为VOA慢速英语改编了这个故事。

Kratos

保持饥渴的专注,追求最佳的品质

US Health Officials Call for Shots Against Pneumonia